About AVPN
Who We Are
We are a leading ecosystem builder that is increasing the flow of financial, human, and intellectual capital from Asia and around the world into the social sector in Asia. We provide a network of peers, rigorous learning programmes, and innovative capital mobilization opportunities that make sure resources are more effectively deployed.
Membership Benefits
Unrestricted access to AVPN research reports and case studies
Access market-specific snapshots and opportunities
Increased visibility for events, programs and insights via AVPN website, blog, newsletters and social media channels
Leverage the AVPN platform to bring under-represented social issues top of mind for more than 600 social investors
Resources
Highlights of the week
Accelerating Impact with Catalytic Capital
Asia sees a growing number of untapped opportunities to support underserved populations, early-stage innovations, and underfunded sectors.
Trust-Based Philanthropy
In the face of increasingly complex and, sometimes rapidly, changing needs on the ground, it is crucial to take a step back and reconsider the status quo.
APAC Sustainability Seed Fund 2.0
By leveraging the success of the first round of the APAC Sustainability Seed Fund, AVPN continues to mobilise continuum of capital into supporting climate solutions in the region.
Markets
We are a leading ecosystem builder that is increasing the flow of financial, human, and intellectual capital from Asia and around the world into the social sector in Asia. We provide a network of peers, rigorous learning programmes, and innovative capital mobilization opportunities that make sure resources are more effectively deployed.
Explore Markets
Impact Communities
Capital Mobilisation
Featured Deals
ReCircle: A Clean-tech Innovator on a mission to Create a Circular Economy
Water and Sanitation and Hygiene
Banka Bio: Sustainable solutions for WaSH needs in India
Water and Sanitation and Hygiene
Fair Employment Foundation: Transforming Recruitment System for Migrant Workers in Asia Pacific
Employability, Financial Inclusion, Gender, Livelihood and Poverty Alleviation
Cool Australia: Supporting Educators Globally through Cool+
Education
HOT-Open Mapping Hub (Asia- Pacific): Transforming Disaster Response, Humanitarian Action and Community Development through Open Source Technologies and Maps
Climate Action and Environment, Gender, Livelihood and Poverty Alleviation
Shelter Associates: Solutions to transform lives of Urban Poor in India
Affordable Housing, Gender, Governance, Health, Water and Sanitation and Hygiene
Events
AVPN Global Conference 2024
As AVPN counts down to the 12th edition of the Annual Global Conference, which will take place against the backdrop of a world in great flux, it is imperative that we provide the social investment community with the most extensive opportunity yet, to learn, connect, and unite in action for Asia.
23 April 2024
-
25 April 2024
Signature Event
Upcoming Events
Nominations for the 2024 Yidan Prize
31 March 2024
AVPN Monthly Member Meet-ups in Bangkok
29 February 2024
Regular Event
Click here to learn more about the Impact Organisation
This is member exclusive
content. Click here to unlock
30 people die from asthma each day. Asthma symptoms are not specific and the diagnosis is heavily dependent on a detailed clinical history with some supporting clinical findings and supportive investigative tests; there is no specific diagnostic test for asthma. It is also common for patients not to present any asthma symptoms at the time of their clinical visit. Without a gold standard test available today, asthma diagnosis is still principally based on a patient’s thorough medical history recorded by experienced clinicians orally instead of clinical evidence. This is a highly subjective approach for young children especially to describe their medical history accurately. The current practice of asthma diagnosis is therefore subjective and requires several repeated follow-up visitations by patients before appropriate medication can be prescribed to patients to control their symptoms. This process can take up to years, endangering a patient’s life from inadequate treatment control plan.
At AEVice Health, we have developed a solution to tackle this problem. Using our proprietary technology, the AEvice device can provide a continuous longitudinal (i.e. over a long duration covering possibly pre-attack, attack and post-attack events) measurement on a patient’s the breathing pattern, duration of wheeze and the intensity of coughs. Most importantly, this device can also be used for young children (and also elderly bed-ridden patients). AEvice device empowers patients to take early intervention and achieve better clinical outcomes, reducing hospital visits and help reduce long-term medical cost. For the first time ever, it also empowers clinicians with objective data to better diagnose their patients faster and tailor a more personalised treatment.